Insmed Stock (NASDAQ: INSM) stock price, news, charts, stock research, profile.
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Other companies in Insmed’s space includes: Exact Sciences (NASDAQ:EXAS), BeiGene (NASDAQ:ONC), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Amgen (NASDAQ:AMGN).
Insmed has a consensus price target of $81.39.
The stock price for Insmed (NASDAQ: INSM) is $81.85 last updated February 21, 2025 at 5:39 PM EST.
There are no upcoming dividends for Insmed.
Insmed’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.